710 Keynote-B59: dose escalation of a phase 1/2 first-in-human, open-label study of GI-101, a novel immunocytokine combining CD80-IL2v, in combination with pembrolizumab in advance... by Cho, Byoung Chul, Lee, Jae Lyun, Shin, Sang Joon, Shim, Byoung Yong, Lee, Hyo Jin, Lee, Jung-Yun, Powderly, John, Lee, Soohyeon, Cohen, Julia, Yun, Nari, Ham, Mina, Lee, Kyoyoung, Kang, Hyunjin, Pyo, Kyoung-Ho, Kim, Jea Hwan, Kim, Mi hyun, Kim, Dong, Jang, Myoung Ho

Get full text